KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Other Non Operating Income (2020 - 2023)

Historic Other Non Operating Income for AbCellera Biologics (ABCL) over the last 4 years, with Q4 2023 value amounting to $3.4 million.

  • AbCellera Biologics' Other Non Operating Income rose 10155.22% to $3.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $14.4 million, marking a year-over-year increase of 3618.53%. This contributed to the annual value of $62.3 million for FY2024, which is 33997.17% up from last year.
  • AbCellera Biologics' Other Non Operating Income amounted to $3.4 million in Q4 2023, which was up 10155.22% from $2.8 million recorded in Q3 2023.
  • Over the past 5 years, AbCellera Biologics' Other Non Operating Income peaked at $7.8 million during Q2 2020, and registered a low of -$2.3 million during Q3 2020.
  • In the last 4 years, AbCellera Biologics' Other Non Operating Income had a median value of $3.3 million in 2021 and averaged $2.9 million.
  • In the last 5 years, AbCellera Biologics' Other Non Operating Income soared by 38002.11% in 2021 and then tumbled by 6846.76% in 2022.
  • Quarter analysis of 4 years shows AbCellera Biologics' Other Non Operating Income stood at -$1.9 million in 2020, then skyrocketed by 380.02% to $5.3 million in 2021, then crashed by 68.47% to $1.7 million in 2022, then skyrocketed by 101.55% to $3.4 million in 2023.
  • Its Other Non Operating Income was $3.4 million in Q4 2023, compared to $2.8 million in Q3 2023 and $4.6 million in Q2 2023.